Table 4 Baseline characteristics according to pocket hematoma
Variables | PH positive group (n = 26) | PH negative group (n = 109) | P-value |
|---|---|---|---|
Age | 64 ± 12 | 59 ± 11 | 0.037 |
Male, n (%) | 14 (53.8) | 67 (61.5) | 0.624 |
Body mass index (kg/m2) | 26.1 ± 5.7 | 25.3 ± 4.3 | 0.396 |
Smoking, n (%) | 3 (11.5) | 19 (17.4) | 0.567 |
Hypertension, n (%) | 18 (69.2) | 56 (51.4) | 0.154 |
Diabetes mellitus, n (%) | 7 (26.9) | 39 (35.8) | 0.531 |
Previous CABG, n (%) | 9 (34.6) | 34 (31.2) | 0.918 |
Ejection fraction, % | 32 (25–55) | 34 (20–55) | 0.210 |
COPD, n (%) | 3 (11.5) | 16 (14.7) | 1.0 |
Hemoglobin, g/dL | 13.2 (10.8–15.1) | 12.8 (9.5–14.5) | 0.946 |
Platelet count, K/mm3 | 239 ± 69 | 246 ± 55 | 0.630 |
BUN, mg/dL | 30.2 (25–39) | 31.6 (22–45) | 0.975 |
Creatinine, mg/dL | 1.0 ± 0.4 | 1.1 ± 0.4 | 0.614 |
Atrial fibrillation, n (%) | 10 (38.5) | 33 (30.3) | 0.568 |
Metallic prosthetic valve, n (%) | 11 (42.3) | 43 (39.4) | 0.964 |
LV thrombus, n (%) | 4 (15.4) | 5 (4.6) | 0.069 |
Recent stent implantation, n (%) | 23 (88.5) | 40 (36.7) | <0.001 |
Medications | |||
ACEI/ARB, n (%) | 22 (84.6) | 73 (67.0) | 0.126 |
Beta blocker, n (%) | 24 (92.3) | 88 (80.7) | 0.245 |
Diuretic, n (%) | 21 (80.8) | 78 (71.6) | 0.479 |
Spironolactone, n (%) | 19 (73.1) | 48 (44.0) | 0.015 |
Statin, n (%) | 13 (50.0) | 49 (45.0) | 0.807 |
Warfarin, n (%) | 4 (15.4) | 68 (62.4) | <0.001 |
DAPT, n (%) | 7 (26.9) | 30 (27.5) | 1.0 |
Warfarin plus DAPT, n (%) | 15 (57.7) | 11 (10.1) | <0.001 |